Clinical Trial Update: The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy

View source ↗

Summary

This trial update reports on a study examining the molecular mechanisms underlying late-onset Fuchs endothelial corneal dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fuchs Endothelial Corneal Dystrophy

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Fuchs' Endothelial Dystrophy | Status: COMPLETED